Status:
ACTIVE_NOT_RECRUITING
Methocarbamol in Ventral and Inguinal HR
Lead Sponsor:
Prisma Health-Upstate
Conditions:
Ventral Hernia
Inguinal Hernia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to gather information on methocarbamol as a pain management treatment for ventral or inguinal hernia repair. Methocarbamol has been part of the pain management treatment ...
Eligibility Criteria
Inclusion
- \>18 y/o
- Patients undergoing open primary ventral hernia repair (group 1)
- Patients undergoing inguinal hernia repair (open, laparoscopic, or robotic; group 2)
- Patients undergoing open incisional hernia repair (group 3)
- Robotic repair ventral or incisional hernias (group 4)
- Given consent for randomization
Exclusion
- \<18 y/o
- Pregnancy
- Chronic opioid users
Key Trial Info
Start Date :
June 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT05388929
Start Date
June 23 2022
End Date
December 1 2026
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prisma Health
Greenville, South Carolina, United States, 29615